GreenLight Biosciences Holdings
GRNA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -67.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | – | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,412.1% | – | -5,244% | -921.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,616.8% | – | -5,642.3% | -965.2% |
| EPS Diluted | -1.27 | -0.93 | -0.56 | -0.3 |
| % Growth | -36.6% | -66.1% | -86.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |